Dual-function antibodies to Yersinia pestis LcrV required for pulmonary clearance of plague

Clinical and Vaccine Immunology

Volumn 16, Issue 12, 2009, Pages 1720-1727

  Eisele, Nicholas A ^a,b   Anderson, Deborah M ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4G2; MONOCLONAL ANTIBODY AH1; MONOCLONAL ANTIBODY B45; MONOCLONAL ANTIBODY LCRV; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; FEMALE; IN VITRO STUDY; INNATE IMMUNITY; LUNG CLEARANCE; MOUSE; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PLAGUE; PRIORITY JOURNAL; YERSINIA PESTIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; CELL LINE; FEMALE; IMMUNOLOGIC FACTORS; MACROPHAGES; MICE; MICE, INBRED C57BL; PHAGOCYTOSIS; PLAGUE; PLAGUE VACCINE; PORE FORMING CYTOTOXIC PROTEINS; YERSINIA PESTIS;

EID: 73449127982     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00333-09     Document Type: Article

References (63)

1. Achtman, M., K. Zurth, G. Morelli, G. Torrea, A. Guiyoule, and E. Carniel. 1999. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc. Natl. Acad. Sci. USA 96:14043-14048.
2. Anderson, D., N. Ciletti, H. Lee-Lewis, D. Elli, J. Segal, K. Overheim, K. DeBord, M. Tretiakova, R. Brubaker, and O. Schneewind. 2009. Pneumonic plague pathogenesis and immunity in Brown Norway rats. Am. J. Pathol. 174:910-921.
3. Anderson, D., and O. Schneewind. 1999. Yersinia enterocolitica type III secretion: an mRNA signal that couples translation and secretion of YopQ. Mol. Microbiol. 31:1139-1148.
4. Anderson, G., P. Worsham, C. Bolt, G. Andrews, S. Welkos, A. Friedlander, and J. Burans. 1997. Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis. Am. J. Trop. Med. Hyg. 56:471-473.
5. Andrews, G., S. Strachen, G. Benner, A. Sample, G. Anderson, J. Adamovicz, S. Welkos, J. Pullen, and A. Friedlander. 1999. Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis. Infect. Immun. 67:1533-1537.
6. Bartlett, A., T. Foster, A. Hayashida, and P. Park. 2008. α-Toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia. J. Infect. Dis. 198:1529-1535.
7. Bashaw, J., S. Norris, S. Weeks, S. Trevino, J. Adamovicz, and S. Welkos. 2007. Development of in vitro correlate assays of immunity to infection with Yersinia pestis. Clin. Vaccine Immunol. 14:605-616.
8. Ben-Efraim, S., M. Aronson, and L. Bichowsky-Slomnicki. 1961. New antigenic component of Pasteurella pestis formed under specific conditions. J. Bacteriol. 81:704-714.
9. Brubaker, R., E. Beesley, and M. Surgalla. 1965. Pasteurella pestis: role of pesticin 1 and iron in experimental plague. Science 149:422-424.
10. Chain, P., E. Carniel, F. Larimer, J. Lamerdin, P. Stoutland, W. Regala, A. Georgescu, L. Vergez, M. Land, V. Motin, R. Brubaker, J. Fowler, B. Hinnebusch, M. Marceau, C. Medigue, M. Simonet, V. Chenal-Francisque, B. Souza, D. Dacheux, J. Elliott, A. Derbise, L. Hauser, and E. Garcia. 2004. Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc. Natl. Acad. Sci. USA 101:13826-13831.
11. Charnetzky, W., and W. Shuford. 1985. Survival and growth of Yersinia pestis within macrophages and an effect of the loss of the 47-megadalton plasmid on growth in macrophages. Infect. Immun. 47:234-241.
12. Clemons, D., C. Besch-Williford, E. Steffen, L. Riley, and D. Moore. 1992. Evaluation of a subcutaneously implanted chamber for antibody production in rabbits. Lab. Anim. Sci. 42:307-311.
13. Cornelis, G. 2006. The type III injectisome. Nat. Rev. Microbiol. 4:811-825.
14. Cornelius, C., L. Quenee, K. Overheim, F. Koster, T. Brasel, D. Elli, N. Ciletti, and O. Schneewind. 2008. Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague. Infect. Immun. 76:5588-5597.
15. Cowan, C., A. Philipovskiy, C. Wulff-Strobel, Z. Ye, and S. Straley. 2005. Anti-LcrV antibodies inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis. Infect. Immun. 73:6127-6137.
16. DeBord, K., D. Anderson, M. Marketon, K. Overheim, R. DePaolo, N. Ciletti, B. Jabri, and O. Schneewind. 2006. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect. Immun. 74:4910-4914.
17. Derewenda, U., A. Mateja, Y. Devedjiev, K. Routzahn, A. Evdokimov, Z. Derewenda, and D. Waugh. 2004. The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague. Structure 12:301-306.
18. Donnenberg, M., and J. Kaper. 1991. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive selection suicide vector. Infect. Immun. 59:4310-4317.
19. Du, Y., R. Rosqvist, and A. Forsberg. 2002. Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect. Immun. 70:1453-1460.
20. Federal Register. 2002. New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible, final rule. Fed. Regist. 67:37988-37998.
21. Forman, S., C. Wulff, T. Myers-Morales, C. Cowan, R. Perry, and S. Straley. 2008. yadBC of Yersinia pestis, a new virulence determinant for bubonic plague. Infect. Immun. 76:578-587.
22. Friedlander, A., S. Welkos, P. Worsham, G. Andrews, D. Heath, G. Anderson, M. Pitt, J. Estep, and K. Davis. 1995. Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin. Infect. Dis. 21:S178-181.
23. Galimand, M., A. Guiyoule, G. Gerbaud, B. Rasoamanana, S. Chanteau, E. Carniel, and P. Courvalin. 1997. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N. Engl. J. Med. 337:677-680.
24. Galván, E., M. Lasaro, and D. Schifferli. 2008. Capsular antigen fraction 1 and Pla modulate the susceptibility of Yersinia pestis to pulmonary antimicrobial peptides such as cathelicidin. Infect. Immun. 76:1456-1464.
25. Goure, J., P. Broz, O. Attree, G. Cornelis, and I. Attree. 2005. Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes. J. Infect. Dis. 192:218-225.
26. Guiyoule, A., G. Gerbaud, C. Buchrieser, M. Galimand, L. Rahalison, S. Chanteau, P. Courvalin, and E. Carniel. 2001. Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis. Emerg. Infect. Dis. 7:43-48.
27. Heath, D., G. Anderson, M. Mauro, S. Welkos, G. Andrews, J. Adamovicz, and A. Friedlander. 1998. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16:1131-1137.
28. Hill, J., C. Copse, S. Leary, A. Stagg, E. Williamson, and R. Titball. 2003. Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis. Infect. Immun. 71:2234-2238.
29. Hill, J., S. Leary, K. Griffin, E. Williamson, and R. Titball. 1997. Regions of Yesinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect. Immun. 65:4476-4482.
30. Hill, J., S. Leary, S. Smither, A. Best, J. Pettersson, A. Forsberg, B. Lingard, K. Brown, A. Lipka, E. Williamson, and R. Titball. 2009. N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infection. Vaccine [Epub ahead of print] doi: 10.1016/j.vaccine.2009.09. 061.
31. Hinnebusch, B., M. Rosso, T. Schwan, and E. Carniel. 2002. High-frequency conjugative transfer of antibiotic resistance genes to Yersinia pestis in the flea midgut. Mol. Microbiol. 2:349-354.
32. Humphrey, W., A. Dalke, and K. Schulten. 1996. VMD: visual molecular dynamics. J. Mol. Graph. 14:27-38.
33. Inglesby, T., D. Dennis, D. Henderson, J. Bartlett, M. Ascher, E. Eitzen, A. Fine, A. Friedlander, J. Hauer, J. Koerner, M. Layton, J. McDade, M. Osterholm, T. O'Toole, G. Parker, T. Perl, P. Russell, M. Schoch-Spana, and K. Tonat. 2000. Plague as a biological weapon: medical and public health management. Working group on civilian biodefense. JAMA 283:2281-2290.
34. - Yersinia pestis. Infect. Immun. 76:5181-5190.
35. Kummer, L., F. Szaba, M. Parent, J. Adamovicz, J. Hill, L. Johnson, and S. Smiley. 2008. Antibodies and cytokines independently protect against pneumonic plague. Vaccine 26:6901-6907.
36. Lathem, W., S. Crosby, V. Miller, and W. Goldman. 2005. Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity. Proc. Natl. Acad. Sci. USA 102:17786-17791.
37. Monack, D., J. Mecsas, N. Ghori, and S. Falkow. 1997. Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc. Natl. Acad. Sci. USA 94:10385-10390.
38. Motin, V., R. Nakagima, G. Smirnov, and R. Brubaker. 1994. Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect. Immun. 62:4192-4201.
39. Mueller, C., P. Broz, S. Muller, P. Ringler, F. Erne-Brand, I. Sorg, M. Kuhn, A. Engel, and G. Cornelis. 2005. The V-antigen of Yersinia forms a distinct structure at the tip of the injectisome needle. Science 310:674-676.
40. Overheim, K., R. DePaolo, K. KeBord, E. Morrin, D. Anderson, N. Green, R. Brubaker, B. Jabri, and O. Schneewind. 2005. LcrV plague vaccine with altered immunomodulatory properties. Infect. Immun. 73:5152-5159.
41. Parent, M., K. Berggren, I. Mullarky, F. Szaba, L. Kummer, J. Adamovicz, and S. Smiley. 2005. Yersinia pestis V protein epitopes recognized by CD4 T cells. Infect. Immun. 73:2197-2204.
42. Parent, M., L. Wilhelm, L. Kummer, F. Szaba, I. Mullarky, and S. Smiley. 2006. Gamma interferon, tumor necrosis factor alpha, and nitric oxid synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection. Infect. Immun. 74:3381-3386.
43. Perry, R. D., and J. Fetherston. 1997. Yersinia pestis-etiologic agent of plague. Clin. Microbiol. Rev. 10:35-66.
44. Peters, N., D. Dixon, S. Holland, and A. Fauci. 2008. The research agenda of the National Institute of Allergy and Infectious Diseases for antimicrobial resistance. J. Infect. Dis. 197:1087-1093.
45. Pullen, J., G. Anderson, S. Welkos, and A. Friedlander. 1998. Analysis of the Yersinia pestis V protein for the presence of linear antibody epitopes. Infect. Immun. 66:521-527.
46. Quenee, L., C. Cornelius, N. Ciletti, D. Elli, and O. Schneewind. 2008. Yersinia pestis caf1 variants and the limits of plague vaccine protection. Infect. Immun. 76:2025-2036.
47. Sarker, M., C. Neyt, I. Stainier, and G. Cornelis. 1998. The Yersinia Yop virulon: LcrV is required for extrusion of the translocators YopB and YopD. J. Bacteriol. 180:1207-1214.
48. 2+ response, and virulence of Yersinia pestis. J. Bacteriol. 177:2530-2542.
49. Sofer-Podesta, C., J. Ang, N. Hackett, S. Senina, D. Perlin, R. Crystal, and J. Boyer. 2009. Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge. Infect. Immun. 77:1561-1568.
50. Sun, K., S. Salmon, S. Lotz, and D. Metzger. 2007. Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection. Infect. Immun. 75:1196-1202.
51. Surgalla, M., and E. Beesley. 1969. Congo red agar plating medium for detecting pigmentation in Pasteurella pestis. Appl. Microbiol. 18:834-837.
52. Swain, S., T. Wright, P. Degel, F. Gigliotti, and A. Harmsen. 2004. Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice. Infect. Immun. 72:5722-5732.
53. Vernazza, C., B. Lingard, H. Flick-Smith, L. Baillie, J. Hill, and H. Atkins. 2009. Small protective fragments of the Yersinia pestis V antigen. Vaccine 27:2775-2780.
54. Wang, S., D. Heilman, F. Liu, T. Giehl, S. Joshi, X. Huang, T. Chou, J. Goguen, and S. Lu. 2004. A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague. Vaccine 22:3348-3357.
55. Weeks, S., J. Hill, A. Friedlander, and S. Welkos. 2002. Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis. Microb. Pathol. 32:227-237.
56. Welch, T., W. Fricke, P. McDermott, D. White, M. Rosso, D. Rasko, M. Mammel, M. Eppinger, M. Rosovitz, D. Wagner, L. Rahalison, J. LeClerc, J. Hinshaw, L. Lindler, T. Cebula, E. Carniel, and J. Ravel. 2007. Multiple antimicrobial resistance in plague: an emerging public health risk. PLoS One 2:1-6.
57. Welkos, S., S. Norris, and J. Adamovicz. 2008. Modified caspase-3 assay indicates correlation of caspase-3 activity with immunity of nonhuman primates to Yersinia pestis infection. Clin. Vaccine Immunol. 15:1134-1137.
58. Wilkinson, T., K. Dhaliwal, T. Hamilton, A. Lipka, L. Farrell, D. Davidson, R. Duffin, A. Morris, C. Haslett, J. Govan, C. Gregory, J. Sallenave, and A. Simpson. 2009. Trappin-2 promotes early clearance of Pseudomonas aeruginosa through CD14 dependent macrophage activation and neutrophil recruitment. Am. J. Pathol. 174:1338-1346.
59. Williamson, E., S. Eley, A. Stagg, M. Green, P. Russell, and R. Titball. 2000. A single dose sub-unit vaccine protects against pneumonic plague. Vaccine 19:566-571.
60. Williamson, E., H. Flick-Smith, C. LeButt, C. Rowland, S. Jones, E. Waters, R. Gwyther, J. Miller, P. Packer, and M. Irving. 2005. Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect. Immun. 73:3598-3608.
61. Williamson, E., H. Flick-Smith, E. Waters, J. Miller, I. Hodgson, C. LeButt, and J. Hill. 2007. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates. Microb. Pathol. 42:11-21.
62. Zauberman, A., S. Cohen, Y. Levy, G. Halperin, S. Lazar, B. Velan, A. Shafferman, Y. Flashner, and E. Mamroud. 2008. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague. Vaccine 26:1616-1625.
63. Zhang, Y., J. Murtha, M. Roberts, R. Siegel, and J. Bliska. 2008. Type III secretion decreases bacterial and host survival following phagocytosis of Yersinia pseudotuberculosis by macrophages. Infect. Immun. 76:4299-4310.